The supplement industry often adds new buzzwords to familiar products. Lately, that word is liposomal. If you’ve looked at NMN supplements then you’ve probably seen it: Liposomal NMN. Advanced bioavailability. Next-generation delivery. Superior absorption technology.
It sounds like progress, and that’s the point. But before you pay extra for NMN with a lipid shell, ask yourself a question the ads skip: What problem is this supposed to solve, and does NMN even have that problem?
In this article
What Liposomal Technology Was Actually Built For
In the right situations, Liposomal Encapsulation is actually really impressive. This technology wraps an active compound inside a tiny lipid sphere, or fat bubble, which protects it from breaking down in the digestive tract and helps it enter the bloodstream more easily.
This method was created for compounds that are hard to absorb, like some fat-soluble vitamins or large, complex molecules that break down in the gut before they can work. For these, liposomal delivery is a real solution to a real problem.
The supplement industry saw that “liposomal” sounds impressive and began using it for many products, including NMN. That’s where the logic falls apart.
NMN Doesn’t Have an Absorption Problem
The pitch for liposomal NMN wants you to believe that NMN is hard to absorb and needs special technology to work well. That’s not true.
NMN is a small, water-soluble molecule. It doesn’t need fat to cross cell membranes, and it isn’t broken down in the gut before your body can use it. The small intestine absorbs NMN using special transport proteins, like Slc12a8, which are made to move NMN efficiently into your bloodstream. Your body already knows how to handle NMN without any help from a lipid shell.
This is the side of the liposomal story that marketing never mentions. The argument for liposomal NMN is based on a bioavailability problem that research doesn’t support. In short, you’re being sold a solution to a problem you don’t have.
What You’re Actually Getting When You Buy Liposomal NMN
Let’s put the absorption debate aside and look at what liposomal encapsulation actually does to a capsule.
A capsule only has so much space. When some of that space is taken up by a lipid shell – the coating that makes it “liposomal” – there’s less room for NMN. This means liposomal NMN products often have less NMN per capsule than regular ones. Sometimes, it’s not a small difference. Some products offer 100mg or less of NMN per capsule, with enough coating to call it advanced, and then charge more for it.
So what does this mean for you? You pay more per capsule and get less NMN, all for an absorption benefit that isn’t backed by science for a compound that already absorbs well. The extra cost is just for the packaging, not for better results.
In fact, the liposomal format works against itself: more coating, less NMN, and a higher price for a lower dose. That’s not a delivery breakthrough – it’s just a way to increase profit margins.
What AVEA Does Instead – And Why
AVEA’s NMN gives you 250mg of Longevir™ in each capsule. There’s no lipid shell, no encapsulation, and no coating taking up space that should be filled with the compound you’re paying for.
Longevir™ is a European-sourced NMN, made to at least 99% purity and 3rd party tested in Swiss labs. This level of purity is important because NMN quality can vary a lot on the open market – some products are priced so low that the raw material must be low grade. AVEA tests to make sure that’s not the case. What’s on the label is what’s in the capsule.
The 250mg dose is important, too. Research on NMN’s effects on NAD+ metabolism – including the PRUVN and RENEW studies, which found a 44% increase in intracellular NAD+ and improvements in sleep and wellbeing – used doses in this range. AVEA’s formula is based on what the evidence supports, not what fits inside a thickly coated capsule.
AVEA hasn’t used liposomal technology because there’s no scientific reason to do so. NMN absorbs well at effective doses without encapsulation. Adding a lipid shell would lower the NMN content, raise the price, and only make the label sound more impressive. That trade-off only benefits the company’s profit margin, not you.
The Bottom Line
Liposomal NMN sounds appealing, but it’s based on a weak argument. The technology is real, but it was made for compounds that NMN isn’t like. NMN already absorbs well on its own. Putting it in a lipid shell doesn’t help – it just raises the price, lowers the dose, and gives marketers something new to promote.
When you’re choosing NMN, what really matters are purity, dose, and independent testing. The delivery method, the coating, and the fancy words on the bottle don’t change what you’re actually getting.
AVEA’s NMN gives you 250mg of Longevir™NMN per capsule, at least 99% pure, tested in Switzerland, and nothing extra. No shell, no filler, and no extra charge for technology you don’t need.
If you want NMN that truly works, this is a good place to begin.
Frequently Asked Questions
Why doesn’t AVEA’s NMN use liposomal delivery?
Because NMN doesn’t need it. NMN is a small, water-soluble molecule that absorbs efficiently on its own. Adding a lipid shell would only reduce the amount of NMN per capsule and increase the price – neither of which benefits you.
What is Longevir™?
Longevir™ is AVEA NMN‘s main ingredient – produced in Europe, manufactured to ≥99% purity, and independently tested in Swiss laboratories. It’s the form of NMN we’ve built our formula around because the quality of the raw material is what actually determines the outcome.
Is regular NMN as effective as liposomal NMN?
The research says yes. Every study that has shown meaningful NAD+ increases used regular NMN – not liposomal. The bioavailability problem that liposomal technology is supposed to solve isn’t a problem NMN actually has.
How do I know AVEA’s NMN is high quality?
Most NMN on the market is sourced from low-cost Chinese manufacturers – and at certain price points, that’s the only way the economics work. AVEA sources Longevir™ from Europe and verifies every batch through independent third-party Swiss lab testing. What’s on the label is what’s in the capsule.
Why does purity matter when choosing NMN?
NMN quality varies significantly across the market. Purity determines how much of what’s in the capsule is actually NMN. AVEA’s Longevir™ is ≥99% pure – verified independently, not self-declared.
References
Grozio, A., Mills, K. F., Yoshino, J., Briones-Herrera, A., Dellinger, R. W., Rogers, R., Crozier, W. E., Rujie, N., Imai, S. I., & Raines, K. W. (2019). Slc12a8 is a nicotinamide mononucleotide transporter. Nature Metabolism, 1(1), 47–57.
Mantovani, M., et al. (2024). Sixty-day AVEA Booster + NMN supplementation: An exploratory single-arm study of NAD+, mood, and sleep in adults. AVEA Life AG & PRUVN™ Research.
